Treating pleural effusion depends entirely on why fluid has collected around your lungs in the first place. Some effusions resolve when the underlying condition is managed, while others need the fluid physically removed. The two broad categories, transudative (caused by pressure imbalances, like heart failure) and exudative (caused by inflammation or disease in the lung lining itself), follow different treatment paths.
Treating the Underlying Cause First
Transudative effusions, the kind caused by heart failure, liver disease, or kidney problems, generally do not require drainage unless they’re large enough to make breathing difficult. The primary treatment is addressing whatever is pushing fluid into the pleural space. For heart failure, which is the most common cause, that means removing excess fluid from the body with diuretics.
Loop diuretics are the first-line choice. For someone already taking them at home, the hospital dose is typically doubled and given intravenously for faster effect. If that isn’t enough, a second type of diuretic can be added to work on a different part of the kidney. One large trial found that adding a carbonic anhydrase inhibitor to a loop diuretic increased the rate of successful fluid removal from about 30% to 42% and shortened hospital stays. Newer diabetes medications that also promote water loss through the kidneys have shown a 25% increase in urine output over five days when started early in a hospital admission for heart failure.
If a patient with heart failure has bilateral effusions of similar size, is not feverish, and has no chest pain, a trial of diuretics alone is the standard starting approach. Many of these effusions shrink or disappear entirely without anyone touching the chest.
When Fluid Needs to Be Drained
Thoracentesis, the procedure where a needle is inserted through the chest wall to withdraw pleural fluid, serves two purposes: figuring out what’s causing the effusion and relieving symptoms. There are no absolute contraindications to performing it. It is commonly done as an outpatient procedure, meaning you go home the same day. You may cough for up to an hour afterward as your lung re-expands, which is normal.
When performed with ultrasound guidance, the complication rate is low. In a study of 941 procedures, pneumothorax (a small air leak into the chest cavity) occurred in about 2.5% of cases, and less than 1% of patients needed a chest tube to fix it. Pain occurred in roughly 3% of cases. Serious bleeding was rare, at about 0.2%. Without ultrasound guidance, complication rates climb considerably, with one older study reporting some type of adverse event in nearly half of procedures, though most were minor.
Infection-Related Effusions
Effusions that develop alongside pneumonia, called parapneumonic effusions, fall into two categories with very different treatment needs. Uncomplicated parapneumonic effusions typically resolve with antibiotics alone and do not require a chest tube.
Complicated parapneumonic effusions and empyema (frank pus in the pleural space) require drainage, and prompt drainage matters. Delayed treatment can lead to thick scar tissue forming on the lung surface, permanently trapping the lung and reducing its function. Any one of the following findings in the drained fluid is an indication for chest tube placement:
- Visible pus in the fluid
- Bacteria visible on gram staining
- Glucose below 50 mg/dL in the pleural fluid
- Pleural fluid pH below 7.20 (at least 0.15 units lower than the blood pH taken at the same time)
These pH and glucose cutoffs apply specifically to infection-related effusions. A low pH in a malignant effusion, for instance, means something different and doesn’t automatically trigger tube placement.
Managing Malignant Pleural Effusions
When cancer causes fluid to accumulate around the lungs, the effusion tends to come back after drainage. Treatment focuses on controlling symptoms and preventing recurrence rather than curing the underlying disease. Two main options exist: pleurodesis and indwelling pleural catheters.
Pleurodesis
Pleurodesis involves introducing a substance into the pleural space that causes the two layers of the lung lining to stick together, eliminating the space where fluid collects. Talc is the most effective and widely used agent, with overall success rates between 80% and 95%. A meta-analysis comparing talc to other substances found it significantly superior in preventing fluid recurrence.
Talc can be delivered in two ways: as a dry powder sprayed during a camera-guided procedure, or as a slurry injected through a chest tube at the bedside. Both approaches work similarly well. One trial found fluid control rates of 78% for the spray method versus 71% for the slurry method, and a larger trial confirmed no meaningful difference in failure rates between the two (22% versus 24%).
Indwelling Pleural Catheters
An indwelling pleural catheter is a thin, tunneled tube that stays in your chest and allows you or a caregiver to drain fluid at home, typically every few days. The TIME2 trial, published in JAMA, compared indwelling catheters directly to talc pleurodesis and found no significant difference in breathlessness relief or quality of life between the two approaches. Indwelling catheters do reduce time spent in the hospital, but they carry a higher rate of adverse events, including infection risk from the external drain site.
The choice between pleurodesis and an indwelling catheter often comes down to individual circumstances. Pleurodesis requires the lung to fully expand against the chest wall to work. If the lung is “trapped,” meaning tumor or scar tissue prevents it from expanding, pleurodesis will fail, and an indwelling catheter becomes the better option.
Surgical Options for Complex Cases
Video-assisted thoracoscopic surgery (VATS) enters the picture when simpler approaches fail or when the situation is more complex. It uses small incisions and a camera to access the pleural space directly, and it has a 95% sensitivity rate for diagnosing malignancy when tissue sampling is needed.
The surgical approach depends on whether the lung can expand. If the lung expands normally, VATS can be used to apply chemical pleurodesis directly under visual guidance or, more aggressively, to strip part of the outer lung lining to prevent fluid from reaccumulating. When the lung is trapped by tumor or scar tissue, the surgeon may attempt to peel away the restrictive layer (decortication) to free the lung, though this is technically demanding. If an effusion becomes infected on top of being malignant, creating a malignant empyema, surgical cleaning of the pleural space is often necessary.
What Recovery Looks Like
Recovery varies enormously depending on the procedure. A simple thoracentesis is same-day: you go home with a small bandage and resume normal activities within a day or two. The main restriction is avoiding heavy lifting for about 48 hours. A chest tube for an infected effusion means a hospital stay that can range from several days to over a week, depending on how quickly the infection clears and drainage slows.
Pleurodesis typically requires two to five days in the hospital while the chest tube remains in place and drainage is monitored. The procedure itself can cause temporary chest pain and fever as the pleural surfaces become inflamed and adhere to each other. Indwelling pleural catheters allow you to leave the hospital quickly, but they require ongoing maintenance at home, with regular drainage sessions and attention to keeping the site clean. Some patients with indwelling catheters eventually develop spontaneous pleurodesis as the two pleural layers stick together on their own, at which point the catheter can be removed.
For effusions caused by heart failure or other treatable conditions, full resolution is possible once the underlying disease is well controlled. Malignant effusions are managed rather than cured, with the goal of keeping you comfortable and breathing as easily as possible for as long as possible.